Structure

Physi-Chem Properties

Molecular Weight:  206.13
Volume:  231.882
LogP:  3.687
LogD:  3.318
LogS:  -3.701
# Rotatable Bonds:  4
TPSA:  37.3
# H-Bond Aceptor:  2
# H-Bond Donor:  1
# Rings:  1
# Heavy Atoms:  2

MedChem Properties

QED Drug-Likeness Score:  0.822
Synthetic Accessibility Score:  2.192
Fsp3:  0.462
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.377
MDCK Permeability:  3.547169399098493e-05
Pgp-inhibitor:  0.0
Pgp-substrate:  0.002
Human Intestinal Absorption (HIA):  0.003
20% Bioavailability (F20%):  0.002
30% Bioavailability (F30%):  0.001

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.463
Plasma Protein Binding (PPB):  94.36505126953125%
Volume Distribution (VD):  0.238
Pgp-substrate:  3.6475677490234375%

ADMET: Metabolism

CYP1A2-inhibitor:  0.079
CYP1A2-substrate:  0.317
CYP2C19-inhibitor:  0.057
CYP2C19-substrate:  0.91
CYP2C9-inhibitor:  0.416
CYP2C9-substrate:  0.982
CYP2D6-inhibitor:  0.004
CYP2D6-substrate:  0.101
CYP3A4-inhibitor:  0.014
CYP3A4-substrate:  0.195

ADMET: Excretion

Clearance (CL):  0.778
Half-life (T1/2):  0.687

ADMET: Toxicity

hERG Blockers:  0.018
Human Hepatotoxicity (H-HT):  0.431
Drug-inuced Liver Injury (DILI):  0.946
AMES Toxicity:  0.004
Rat Oral Acute Toxicity:  0.538
Maximum Recommended Daily Dose:  0.015
Skin Sensitization:  0.17
Carcinogencity:  0.072
Eye Corrosion:  0.018
Eye Irritation:  0.586
Respiratory Toxicity:  0.066

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC274454

Natural Product ID:  NPC274454
Common Name*:   (3S,4S,3's,4's)-9,7',9'-Trimethoxy-3,3'-Dimethyl-3,4,3',4'-Tetrahydro-1H,1'h-[5,5']Bi[Benzo[G]Isochromenyl]-4,7,10,4',10'-Pentaol
IUPAC Name:   (3S,4S)-5-[(3S,4S)-4,10-dihydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-5-yl]-9-methoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromene-4,7,10-triol
Synonyms:  
Standard InCHIKey:  AAAGKEAEOHPDBS-SAAODOGCSA-N
Standard InCHI:  InChI=1S/C31H32O10/c1-12-28(33)26-18(10-40-12)30(35)22-16(6-14(32)7-20(22)38-4)24(26)25-17-8-15(37-3)9-21(39-5)23(17)31(36)19-11-41-13(2)29(34)27(19)25/h6-9,12-13,28-29,32-36H,10-11H2,1-5H3/t12-,13-,28+,29+/m0/s1
SMILES:  COc1cc(OC)c2c(c1)c(c1c3[C@H](O)[C@H](C)OCc3c(c3c1cc(O)cc3OC)O)c1c(c2O)CO[C@H]([C@H]1O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL251102
PubChem CID:   23657442
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0001392] Lignans, neolignans and related compounds
      • [CHEMONTID:0001610] Arylnaphthalene lignans

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32515 Cordyceps sp. Under-species n.a. n.a. n.a. n.a. n.a. PMID[17887724]
NPO32514 Cordyceps sp. Under-species n.a. n.a. n.a. n.a. n.a. PMID[17887724]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT6 Organism Plasmodium falciparum Plasmodium falciparum Inhibition < 50.0 % PMID[515074]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC274454 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC215678
0.9928 High Similarity NPC153182
0.9928 High Similarity NPC174251
0.9444 High Similarity NPC162976
0.9444 High Similarity NPC118000
0.9444 High Similarity NPC205501
0.9149 High Similarity NPC273623
0.911 High Similarity NPC321657
0.911 High Similarity NPC318373
0.9085 High Similarity NPC277331
0.9085 High Similarity NPC100482
0.9071 High Similarity NPC472647
0.9071 High Similarity NPC191462
0.9071 High Similarity NPC472649
0.9071 High Similarity NPC170328
0.9071 High Similarity NPC472648
0.9071 High Similarity NPC206525
0.9071 High Similarity NPC133463
0.9034 High Similarity NPC96576
0.9007 High Similarity NPC472646
0.9007 High Similarity NPC71465
0.9 High Similarity NPC37410
0.9 High Similarity NPC258780
0.898 High Similarity NPC211561
0.8973 High Similarity NPC262297
0.8973 High Similarity NPC204770
0.8973 High Similarity NPC236202
0.8973 High Similarity NPC263940
0.8973 High Similarity NPC82917
0.8973 High Similarity NPC70409
0.8973 High Similarity NPC108811
0.8973 High Similarity NPC202742
0.8973 High Similarity NPC58190
0.8973 High Similarity NPC18185
0.8973 High Similarity NPC262911
0.8973 High Similarity NPC294558
0.8973 High Similarity NPC170103
0.8919 High Similarity NPC477612
0.8904 High Similarity NPC126291
0.8897 High Similarity NPC475492
0.8889 High Similarity NPC186033
0.8889 High Similarity NPC183709
0.8849 High Similarity NPC282508
0.8844 High Similarity NPC474397
0.88 High Similarity NPC325860
0.88 High Similarity NPC226809
0.88 High Similarity NPC279406
0.88 High Similarity NPC476391
0.8784 High Similarity NPC20757
0.8784 High Similarity NPC227516
0.8777 High Similarity NPC254000
0.8776 High Similarity NPC102280
0.8776 High Similarity NPC155564
0.8776 High Similarity NPC248053
0.8767 High Similarity NPC28440
0.8767 High Similarity NPC171932
0.8759 High Similarity NPC472088
0.8759 High Similarity NPC472087
0.875 High Similarity NPC12668
0.875 High Similarity NPC308768
0.8742 High Similarity NPC224161
0.8741 High Similarity NPC22902
0.8741 High Similarity NPC470308
0.8741 High Similarity NPC266006
0.8741 High Similarity NPC470307
0.869 High Similarity NPC472089
0.869 High Similarity NPC265075
0.8684 High Similarity NPC46335
0.8681 High Similarity NPC105847
0.8681 High Similarity NPC218131
0.8681 High Similarity NPC243759
0.8681 High Similarity NPC114171
0.8681 High Similarity NPC275061
0.8681 High Similarity NPC220344
0.8681 High Similarity NPC6300
0.8681 High Similarity NPC243996
0.8681 High Similarity NPC230124
0.8681 High Similarity NPC132804
0.8675 High Similarity NPC226108
0.8675 High Similarity NPC272552
0.8675 High Similarity NPC469944
0.8675 High Similarity NPC233467
0.8675 High Similarity NPC44192
0.8675 High Similarity NPC46283
0.8675 High Similarity NPC322899
0.8675 High Similarity NPC59692
0.8675 High Similarity NPC134911
0.8671 High Similarity NPC471522
0.8671 High Similarity NPC472800
0.8667 High Similarity NPC260781
0.8667 High Similarity NPC9933
0.8667 High Similarity NPC469707
0.8667 High Similarity NPC214326
0.8667 High Similarity NPC158784
0.8667 High Similarity NPC182368
0.8667 High Similarity NPC218041
0.8667 High Similarity NPC469706
0.8667 High Similarity NPC225815
0.8667 High Similarity NPC145979
0.8667 High Similarity NPC185955
0.8662 High Similarity NPC473107
0.8658 High Similarity NPC281549
0.8658 High Similarity NPC473876
0.8649 High Similarity NPC14468
0.8649 High Similarity NPC233980
0.8639 High Similarity NPC473108
0.8639 High Similarity NPC473845
0.8633 High Similarity NPC38017
0.8633 High Similarity NPC148366
0.8633 High Similarity NPC215300
0.8633 High Similarity NPC311293
0.863 High Similarity NPC175838
0.8623 High Similarity NPC82299
0.8621 High Similarity NPC472090
0.8621 High Similarity NPC472092
0.8621 High Similarity NPC472091
0.8618 High Similarity NPC306267
0.8618 High Similarity NPC20050
0.8611 High Similarity NPC56329
0.8611 High Similarity NPC266453
0.8611 High Similarity NPC200935
0.8611 High Similarity NPC151656
0.8611 High Similarity NPC242715
0.8611 High Similarity NPC230919
0.8609 High Similarity NPC302915
0.8609 High Similarity NPC471403
0.8609 High Similarity NPC2745
0.8609 High Similarity NPC259707
0.86 High Similarity NPC476969
0.86 High Similarity NPC295573
0.86 High Similarity NPC470208
0.8582 High Similarity NPC473309
0.8582 High Similarity NPC471517
0.8582 High Similarity NPC103799
0.8582 High Similarity NPC160623
0.8571 High Similarity NPC469630
0.8571 High Similarity NPC471518
0.8571 High Similarity NPC471519
0.8562 High Similarity NPC178054
0.8562 High Similarity NPC157333
0.8561 High Similarity NPC473221
0.8561 High Similarity NPC53781
0.8553 High Similarity NPC21902
0.8553 High Similarity NPC120633
0.8553 High Similarity NPC157783
0.8553 High Similarity NPC473018
0.8552 High Similarity NPC184613
0.8552 High Similarity NPC475836
0.8552 High Similarity NPC32630
0.8551 High Similarity NPC293801
0.8543 High Similarity NPC195561
0.8542 High Similarity NPC143139
0.8542 High Similarity NPC202846
0.8542 High Similarity NPC470802
0.8542 High Similarity NPC30632
0.8542 High Similarity NPC141717
0.8533 High Similarity NPC212142
0.8531 High Similarity NPC476615
0.8531 High Similarity NPC125649
0.8531 High Similarity NPC476616
0.8531 High Similarity NPC476617
0.8523 High Similarity NPC471608
0.8523 High Similarity NPC260397
0.8516 High Similarity NPC4809
0.8516 High Similarity NPC147743
0.8516 High Similarity NPC73517
0.8514 High Similarity NPC50250
0.8514 High Similarity NPC304894
0.8514 High Similarity NPC15659
0.85 High Similarity NPC471064
0.8493 Intermediate Similarity NPC34431
0.8493 Intermediate Similarity NPC73505
0.8493 Intermediate Similarity NPC295719
0.8493 Intermediate Similarity NPC174787
0.8493 Intermediate Similarity NPC262189
0.8493 Intermediate Similarity NPC165026
0.8493 Intermediate Similarity NPC213607
0.8493 Intermediate Similarity NPC182509
0.8493 Intermediate Similarity NPC22317
0.8489 Intermediate Similarity NPC170485
0.8472 Intermediate Similarity NPC256262
0.8472 Intermediate Similarity NPC10314
0.8472 Intermediate Similarity NPC241241
0.8472 Intermediate Similarity NPC108198
0.8472 Intermediate Similarity NPC294884
0.8472 Intermediate Similarity NPC200557
0.8472 Intermediate Similarity NPC69029
0.8472 Intermediate Similarity NPC158142
0.8472 Intermediate Similarity NPC125579
0.8472 Intermediate Similarity NPC11727
0.8472 Intermediate Similarity NPC15109
0.8467 Intermediate Similarity NPC111134
0.8467 Intermediate Similarity NPC112819
0.8467 Intermediate Similarity NPC133209
0.8467 Intermediate Similarity NPC6702
0.8462 Intermediate Similarity NPC185231
0.8462 Intermediate Similarity NPC159526
0.8462 Intermediate Similarity NPC86630
0.8462 Intermediate Similarity NPC106601
0.8462 Intermediate Similarity NPC469610

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC274454 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.838 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.8354 Intermediate Similarity NPD6959 Discontinued
0.831 Intermediate Similarity NPD4625 Phase 3
0.8239 Intermediate Similarity NPD4908 Phase 1
0.8138 Intermediate Similarity NPD1613 Approved
0.8138 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.8067 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.8056 Intermediate Similarity NPD3027 Phase 3
0.8 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7988 Intermediate Similarity NPD7228 Approved
0.7947 Intermediate Similarity NPD6674 Discontinued
0.7917 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7862 Intermediate Similarity NPD8455 Phase 2
0.7862 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7847 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7831 Intermediate Similarity NPD5844 Phase 1
0.7762 Intermediate Similarity NPD4749 Approved
0.7746 Intermediate Similarity NPD1610 Phase 2
0.7688 Intermediate Similarity NPD37 Approved
0.7673 Intermediate Similarity NPD4380 Phase 2
0.7669 Intermediate Similarity NPD6234 Discontinued
0.7654 Intermediate Similarity NPD4965 Approved
0.7654 Intermediate Similarity NPD4967 Phase 2
0.7654 Intermediate Similarity NPD4966 Approved
0.7651 Intermediate Similarity NPD6166 Phase 2
0.7651 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7651 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD8453 Clinical (unspecified phase)
0.7636 Intermediate Similarity NPD6232 Discontinued
0.7605 Intermediate Similarity NPD7473 Discontinued
0.7602 Intermediate Similarity NPD8313 Approved
0.7602 Intermediate Similarity NPD8312 Approved
0.7588 Intermediate Similarity NPD7240 Approved
0.7551 Intermediate Similarity NPD2861 Phase 2
0.7546 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7533 Intermediate Similarity NPD4060 Phase 1
0.7529 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD7390 Discontinued
0.7485 Intermediate Similarity NPD6559 Discontinued
0.7485 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7468 Intermediate Similarity NPD7447 Phase 1
0.7465 Intermediate Similarity NPD1548 Phase 1
0.7439 Intermediate Similarity NPD7768 Phase 2
0.7423 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7417 Intermediate Similarity NPD3620 Phase 2
0.7417 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7412 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7405 Intermediate Similarity NPD7041 Phase 2
0.7405 Intermediate Similarity NPD7212 Phase 2
0.7405 Intermediate Similarity NPD7040 Clinical (unspecified phase)
0.7405 Intermediate Similarity NPD7213 Phase 3
0.7403 Intermediate Similarity NPD6099 Approved
0.7403 Intermediate Similarity NPD6100 Approved
0.7401 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7397 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7386 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD7074 Phase 3
0.7368 Intermediate Similarity NPD5735 Approved
0.7366 Intermediate Similarity NPD8151 Discontinued
0.7358 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7356 Intermediate Similarity NPD8054 Approved
0.7356 Intermediate Similarity NPD8053 Approved
0.7347 Intermediate Similarity NPD6696 Suspended
0.7347 Intermediate Similarity NPD8651 Approved
0.7337 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7321 Intermediate Similarity NPD3787 Discontinued
0.7317 Intermediate Similarity NPD7819 Suspended
0.731 Intermediate Similarity NPD7054 Approved
0.7289 Intermediate Similarity NPD7075 Discontinued
0.7284 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD4538 Approved
0.7273 Intermediate Similarity NPD4536 Approved
0.7273 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD7472 Approved
0.7262 Intermediate Similarity NPD7199 Phase 2
0.7256 Intermediate Similarity NPD1934 Approved
0.7255 Intermediate Similarity NPD5124 Phase 1
0.7255 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7244 Intermediate Similarity NPD5762 Approved
0.7244 Intermediate Similarity NPD5763 Approved
0.7244 Intermediate Similarity NPD7266 Discontinued
0.7241 Intermediate Similarity NPD5126 Approved
0.7241 Intermediate Similarity NPD5125 Phase 3
0.7234 Intermediate Similarity NPD4869 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD7229 Phase 3
0.7215 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD1465 Phase 2
0.7208 Intermediate Similarity NPD4097 Suspended
0.72 Intermediate Similarity NPD3018 Phase 2
0.7186 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7184 Intermediate Similarity NPD7251 Discontinued
0.7181 Intermediate Similarity NPD3094 Phase 2
0.7161 Intermediate Similarity NPD7097 Phase 1
0.7158 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD4160 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7808 Phase 3
0.7143 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD2533 Approved
0.7143 Intermediate Similarity NPD1091 Approved
0.7143 Intermediate Similarity NPD7446 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD2534 Approved
0.7143 Intermediate Similarity NPD2532 Approved
0.7133 Intermediate Similarity NPD7157 Approved
0.7126 Intermediate Similarity NPD6797 Phase 2
0.7123 Intermediate Similarity NPD4626 Approved
0.7117 Intermediate Similarity NPD1653 Approved
0.7115 Intermediate Similarity NPD5960 Phase 3
0.7115 Intermediate Similarity NPD5588 Approved
0.711 Intermediate Similarity NPD8156 Discontinued
0.7108 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD7003 Approved
0.7097 Intermediate Similarity NPD7680 Approved
0.7091 Intermediate Similarity NPD7411 Suspended
0.7083 Intermediate Similarity NPD7340 Approved
0.7076 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7071 Intermediate Similarity NPD4750 Phase 3
0.707 Intermediate Similarity NPD2438 Suspended
0.7059 Intermediate Similarity NPD6812 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD5691 Approved
0.7052 Intermediate Similarity NPD8252 Approved
0.7052 Intermediate Similarity NPD8251 Approved
0.7052 Intermediate Similarity NPD3751 Discontinued
0.7052 Intermediate Similarity NPD8099 Discontinued
0.705 Intermediate Similarity NPD2342 Discontinued
0.7047 Intermediate Similarity NPD5327 Phase 3
0.7047 Intermediate Similarity NPD2983 Phase 2
0.7047 Intermediate Similarity NPD2982 Phase 2
0.7044 Intermediate Similarity NPD1652 Phase 2
0.7043 Intermediate Similarity NPD6823 Phase 2
0.7042 Intermediate Similarity NPD7635 Approved
0.7042 Intermediate Similarity NPD7843 Approved
0.7037 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7027 Intermediate Similarity NPD3092 Approved
0.7027 Intermediate Similarity NPD6782 Approved
0.7027 Intermediate Similarity NPD6781 Approved
0.7027 Intermediate Similarity NPD6780 Approved
0.7027 Intermediate Similarity NPD6778 Approved
0.7027 Intermediate Similarity NPD6779 Approved
0.7027 Intermediate Similarity NPD6777 Approved
0.7027 Intermediate Similarity NPD6776 Approved
0.7025 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.7024 Intermediate Similarity NPD4581 Clinical (unspecified phase)
0.7019 Intermediate Similarity NPD5058 Phase 3
0.7016 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7016 Intermediate Similarity NPD7783 Phase 2
0.7014 Intermediate Similarity NPD6671 Approved
0.7006 Intermediate Similarity NPD5929 Approved
0.7005 Intermediate Similarity NPD7435 Discontinued
0.7005 Intermediate Similarity NPD7696 Phase 3
0.7005 Intermediate Similarity NPD7697 Approved
0.7005 Intermediate Similarity NPD7698 Approved
0.7 Intermediate Similarity NPD7466 Approved
0.7 Intermediate Similarity NPD5494 Approved
0.7 Intermediate Similarity NPD3892 Phase 2
0.7 Intermediate Similarity NPD3750 Approved
0.7 Intermediate Similarity NPD4666 Phase 3
0.6993 Remote Similarity NPD1398 Phase 1
0.6988 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6981 Remote Similarity NPD7037 Approved
0.698 Remote Similarity NPD2981 Phase 2
0.697 Remote Similarity NPD4005 Discontinued
0.6968 Remote Similarity NPD2238 Phase 2
0.6968 Remote Similarity NPD4140 Approved
0.6968 Remote Similarity NPD7870 Phase 2
0.6968 Remote Similarity NPD7871 Phase 2
0.6962 Remote Similarity NPD5408 Approved
0.6962 Remote Similarity NPD5406 Approved
0.6962 Remote Similarity NPD5405 Approved
0.6962 Remote Similarity NPD5404 Approved
0.6957 Remote Similarity NPD2677 Approved
0.6948 Remote Similarity NPD6798 Discontinued
0.6947 Remote Similarity NPD7701 Phase 2
0.6946 Remote Similarity NPD6801 Discontinued
0.6944 Remote Similarity NPD7906 Approved
0.6941 Remote Similarity NPD5709 Phase 3
0.6939 Remote Similarity NPD1651 Approved
0.6927 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6918 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6918 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6913 Remote Similarity NPD3705 Approved
0.6913 Remote Similarity NPD1611 Approved
0.6908 Remote Similarity NPD6584 Phase 3
0.6905 Remote Similarity NPD2801 Approved
0.6901 Remote Similarity NPD6746 Phase 2
0.6899 Remote Similarity NPD4108 Discontinued
0.6894 Remote Similarity NPD4628 Phase 3
0.6892 Remote Similarity NPD5846 Approved
0.6892 Remote Similarity NPD6516 Phase 2
0.6889 Remote Similarity NPD8150 Discontinued
0.6887 Remote Similarity NPD1283 Approved
0.6883 Remote Similarity NPD7095 Approved
0.6882 Remote Similarity NPD7975 Clinical (unspecified phase)
0.6882 Remote Similarity NPD3749 Approved
0.6879 Remote Similarity NPD2684 Approved
0.6879 Remote Similarity NPD6353 Approved
0.6875 Remote Similarity NPD2424 Discontinued
0.6875 Remote Similarity NPD1549 Phase 2
0.6875 Remote Similarity NPD970 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data